Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not necessarily, we already have FDA class ll approval, but changes to the product as I mentioned a few post back require recertification—“substantially equivalent” SE to be marketed, Quote, ”Until the submitter receives an order declaring a device SE, the submitter may not proceed to market the device. Once the device is determined to be SE, it can then be marketed in the U.S. The SE determination is usually made within “90 days” and is made based on the information submitted by the submitter.”
Article: We're going to see a lot more consumer tech devices get the FDA's blessing. Here's what you need to know.
June 13, 2019 5:00 a.m. PT
So we do know for fact: Ongoing El Camino trial means iTBra is being “funded & tested”...! (My Investment experience means those words are “code” for 1)El Camino sees merit/potential efficacy in the iTBra or it simply would not be allowed anywhere near their facilities & 2)LLBO outstanding O/S has not been further diluted, because most likely due to the Cyrcadia restructuring several years ago, with Cyrcadia incurring the additional funding for the on going trials...without having to issue any more LLBO shares @ sub penny valuation.
“Elementary, my dear Watson”
You know this stock is like a big big big Craps table, you buy the dice (bet on a number) & roll them, but they just keep rolling in perpetual motion, someday the dice will stop rolling & land on a number...? Every day the dice are slowing down...!!!
FDA approval after trial is completed... & we all know it’s been a while...so I’d only be guessing as to when that will be 6 months—1 year—etc. I think if we draw off what has occurred recently per one article I read, more than 1/2 cancer patients not getting treated due to Covid-19, so none of us want to hear it, but the iTBra trial has probably slowed down as well...(as I said before “funding” without further dilution is key here *#%^<~*%<~!¥* hint hint...!).
13
Email from iTBra Trial Coordinator, my personal info removed, u can contact Karen yourself.
Sent from Mail for Windows 10
From: Kara Turner <Kara_Turner@elcaminohealth.org>
Sent: Thursday, April 30, 2020 1:14:37 PM
To: 'Mxxxxx xxxxxx mxxxxxxx@hotmail.com>
Subject: RE: Cyrcadian breast cancer screen trial
Hello,
Thank you for reaching out about this clinical trial. Patients will be considered for participation in this study if they are scheduled for a breast biopsy due to a suspicious imaging test at the Breast Health Center at El Camino Hospital.
Best Regards,
Kara Turner, BS, CCRP
Senior Clinical Research Coordinator, Taft Center for Clinical Research
El Camino Hospital | 2500 Grant Road, M/S ECH 115, Mountain View, CA 94040
Ph: 650-962-4562 | Fax: 650-962-4622 | kara_turner@elcaminohealth.org
Notice: This email and any attachments are intended only for the named recipient(s), and may include confidential, proprietary or legally privileged information. If you are not the intended recipient, you are not authorized to copy, print, share, save or rely upon this email or any attachments; instead please notify the sender by reply and immediately destroy this email and any attachments.
Please consider the environment before printing this e-mail.
-----Original Message-----
From: Mxxxxxx xxxxxxxx[mailto xxxxxxx@hotmail.com]
Sent: Thursday, April 30, 2020 7:05 AM
To: Kara Turner
Subject: Cyrcadian breast cancer screen trial
WARNING: This email originated outside of the El Camino Hospital email system! DO NOT CLICK links if the sender is unknown, and never provide your User ID or Password.
----------------------------------------------------------------------
Hello, was wondering if the breast screening bra patch trial is still open ?
Thank you ??
I’ll post the ElCamino Hospital email when I get home later...the other email I cannot post!
Agree, a little bird telling me testing on going & funded, I wouldn’t be surprised if updates coming, unfortunately not sure if Covid-19 kept people from the clinical trial...13
All good statements/questions !
1-RS is always a possibility, but don’t see it happening here. I think they have their hands full, but it’s anybody’s guess? (Jim Holmes has a very large share & I believe would only act to increase his share value, he is getting up there in age & would like to leave something for his grand children !!!)
2-The company has little value until the already FDA approved class ll approval gets market clearance. (Clinical trials are still on going at El Camino Hospital, testing the newer design & algorithms.—
“Clinical Circadian Thermal Sensing for the Detection of Breast Disease as a Supplemental Cancer Screening System
Services menu
Clinical Trials
Phase: Pilot/Feasibility
Status: Recruiting
The purpose of this study is to determine if the Cyrcadia device can predict if a woman has breast cancer or benign breast tissue. The Cyrcadia device includes two adhesive patches with electrodes that are fitted over each breast. It collects data on the dynamic temperature changes in the breasts over time and transfers acquired data to a processing location which will return results to your physician. To determine the accuracy of this device, it will be tested on a group of women who have been scheduled for a breast biopsy due to a suspicious imaging test.
Principal InvestigatorShiva Singhal, MD
SponsorCyrcadia, Inc.
NCT NumberNCT02511301
ContactKara Turner, Clinical Research Coordinator
Taft Center for Clinical Research
650-962-4562
Kara_Turner@elcaminohealth.org”
(Just contact Kara about open enrollment like I did)
3- Let’s face it until the green light comes on we are going no where, welcome to the world of risk speculation.
(I can only believe it will, as insurance co’s, Hospital telemedicine, user product market acceptance, etc all say hey great).
PPS—$.14 Price Per Share (updated from my 2018 PPS analysis & updated LLBO Cyrcadia Health percentage ownership!)
Fortune Business Insights:
Global | Published Date: Jul, 2019 | Report ID: FBI101065-
“The global telehealth market size valued at USD 49.8 Billion in 2018 and is projected to reach USD 266.8 Billion by 2026, exhibiting a CAGR of 23.4% between 2018 and 2026”
EBITDA valuation: for co’s up to $100Mil.Rev., is normally 5-7x EBITDA(Earnings before interest taxes depreciation and amortization)
40,000,000Mil mammograms yr USA, not including the rest of the world ( or the high dense breast incidents in Asia ), LLBO gets 10% = 4,000,000mil x *$150ea=Revenue of 600,000Mil & avg gross EBITDA profit of 45% =
about $270,000,000 Million,
Value Cyrcadia Health at 5X that profit =(270mil x 5= $1.5 Billion), So
LLBO PPS fair value (LLBO owns 30% of Cyrcadia or $450 Million) so 3.1bill OS share ($.145 PPS)
Now obviously something as big as breast cancer and the need for alternative solutions share price could fluctuate to higher levels on speculation ???
*($150-estimated annual iTBra fee per Cyrcadia)
iTBra FDA Class ll:
FDA class II Substantially changed devices will need to be reviewed before marketing clearance will be issued by the fda...
(simply put can’t market the device due to device applied application time/ AI software changes are re approved )
Your Probably aware the iT Bra went through technology upgrades, these changes substantially changed the
efficacy for the better, but still need FDA review.
This is why their website states-“The product is not currently available for sale in the United States.“
& Cyrcadia Asia states ”FDA Class II clearance issued with further clearances in process.”
Will Covid-19 hasten or impede the FDA & US continued trial...will see ! iFlytec(Keda Xunfei) & Cyrcadia Health
post# 27374
Re-Post: New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast & looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia AI cloud data center which transmits analysis back to her & Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following POST after drinking a pot of coffee!)))
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
27131 PPS it’s long,but conclusion: pps.22 or more
27094 Co marketing intent: the short “it’s happening”!
27061 Market size & Need: Summary-It’s Huge & Needed
26944 Insurance Co perspective: Ho Ho Ho Merry Christmas, AARP nailed it! $$$
27037 Number of breast cancer cases & importance of earl detection: Your life may depend on it
26370 iFlytech Corp.-Invest in healthcare through acquisition: Say what ?
25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia/World
waiting. Other info.
Hell just buy some shares sit back & think of green grass & high tides!!!
Bloomberg Nov, 2017 iFlytec video (6 months After Cyrcadia Asia iT Bra investment)
“China’s iFlytec focuses on smart healthcare” quoted...
—“Smart Healthcare growth (acquisition) is the primary Company smart tech strategic focus”
—Assisted diognostic system accuracy for improved cancer diognosis through AI imaging”
—“Out International strategy of investing in USA Co’s WILL assist this goal”
—Activities are being conducted at our new Silicon Valley...
Read between the lines, LLBO S/B trading above .05 cents per share.
Jim Holmes, Lifeline’sCyrcadia Health CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, sales of our potentially lifesaving product. Our tested and proven technology, from our multiple rounds of clinical trials, has shown early identification of breast tissue abnormalities, many of which could lead to cancers, potentially can save lives and costs. We/Cyrcadia prepared an analysis of cost savings for a presentation to a World-Wide Major Insurance Company. The medical cost comparison was identifying breast tissue abnormalities and breast cancers at stage 1-3, vs the abnormality progressing to stage 4 or 5 cancer. The cost savings was estimated at over $300,000 per patient. Applying this projected and estimated cost savings to this large insurance, was in the hundreds of millions of dollars annually”. (PPS anybody’s guess ?)
Yes, I think he lived near Lake Michigan? I wonder if his wife kept the shares of LLBO...
U too Arnie...The quote was Mead 11’s, from his linkedin page!!!
Mead11 favorite quote:
Nothing is more powerful than an idea whose time has come.' -- Victor Hugo
Clinical trial on going Elcamino Hospital & Much more...prev post!
Clinical Circadian Thermal Sensing for the Detection of Breast Disease as a Supplemental Cancer Screening System
Services menu
Clinical Trials
Phase: Pilot/Feasibility
Status: Recruiting
The purpose of this study is to determine if the Cyrcadia device can predict if a woman has breast cancer or benign breast tissue. The Cyrcadia device includes two adhesive patches with electrodes that are fitted over each breast. It collects data on the dynamic temperature changes in the breasts over time and transfers acquired data to a processing location which will return results to your physician. To determine the accuracy of this device, it will be tested on a group of women who have been scheduled for a breast biopsy due to a suspicious imaging test.
Principal InvestigatorShiva Singhal, MD
SponsorCyrcadia, Inc.
NCT NumberNCT02511301
ContactKara Turner, Clinical Research Coordinator
Taft Center for Clinical Research
650-962-4562
Kara_Turner@elcaminohealth.org
Tuesday, 07/17/18 08:30:45 AM
Re: confirm post# 25848 0
Post # of 30421
“New”Investor Information:
Evolving Role Of Thermal Dynamic Analysis &
Is Telemedicine the Future of Care.
Cyrcadia Health
(Lifeline Biotechnologies
LLBO, PPS your guess ?)
Huge mkt for women who want home privacy & life saving ability to do a simple reliable breast examination between annual breast check ups, the iT Bra allows this peace of mind. With the new breast screening guidelines out recommending screening every other year after age 54, the IT Bra will be ideal for those long in between screenings, oh and the new guidelines also don’t recommend the old self examination “by hand”, hell let’s just let the tumor grow into an elephant. What’s left, the iT Bra or a crystal ball, which would u choose ???
https://www.ncbi.nlm.nih.gov/ (The evolving role of the dynamic thermal analysis in the early detection of breast cancer-National Center For Biotechnology Gov: “Cancer development appears to generate its own thermal signatures and the complexity of these signatures may be a reflection of its degree of development.
The limitations of mammography as a screening modality especially in young women with dense breasts necessitated the development of novel and more effective screening strategies with a high sensitivity and specificity. Dynamic thermal analysis of the breast is a safe, non invasive approach that seems to be sensitive for the early detection of breast tumors . The limitations of mammography as a screening modality especially in young women with dense breasts necessitated the development of novel and more effective screening strategies with a high sensitivity and specificity.st cancer.
With increasing evidence that inflammation can enhance tumor growth and is associated with a poor prognosis, this suggestion implies that thermal analysis may have considerable value [30].
The evolving role (Artificial Intelligence)of the dynamic thermal analysis in the early detection of breast cancer”.
M Salhab, W Al Sarakbi, and K Mokbel
It is now recognised that the breast exhibits a circadian rhythm which reflects its physiology. There is increasing evidence that rhythms associated with malignant cells proliferation are largely non-circadian and that a circadian to ultradian shift may be a general correlation to neoplasia.
Cancer development appears to generate its own thermal signatures and the complexity of these signatures may be a reflection of its degree of development.
The “limitations” of mammography as a screening modality especially in young women with “dense breasts”
necessitated the development of novel and more effective screening strategies with a high sensitivity and specificity. Dynamic thermal analysis of the breast is a safe, non invasive approach that seems to be sensitive for the early detection of breast cancer. End
(iT Bra fits right in)
(Gene identification for breast tumor risk testing is NOT going to change that in any way.)
Cont’d from top:
Is Telemedicine the Future of Care?
One such very large medical Co. that is currently being approached by Cyrcadia Health (iT Bra) is-Kaiser Permanente Co. ( mentioned in AARP article below),
Kaiser preaches “Early Diognostic Prevention”...& the iT Bra is something they cannot afford to shrug off.
Virtual Medical Care Huge Future:
Glad to see that Cyrcadia Health will be indirectly involved with Kaiser Permanent
(I brought this up as a target mkt below, prior to Cyrcadia Health 2017-2018 report release, glad to see they are going right
after the Virtual med mkt.).
Let’s just look at what is literally appearing before our eyes to help answer this question
“This is the future of Medicine...”
Telemedicine Revolution (patients/doctors converse anywhere)—Fact, Hospitals Without Patients (virtual care) 2016 mega growth industry had sales of $14 Billion Dollars, growth projection
expected to $36 Billion Dollars by 2020, (2yrs) WOW, project that growth line and
You fall out of your seat (iT Bra I would say is properly named).
Mercy Virtual medical bldg is 6 miles from my home, a mega structure loaded with over
400 doctors, nurse specialist, &
medical technicians (not one hospital bed). All who supported more than 44 hospitals in the Mercy network,
in over 10 Midwest states (had over 750,000 thousand patients just last year.)
(Why? Patient convenience, privacy, more efficient healthcare, saving money & more important life’s).
1)Mercy Virtual 2)Kaiser Permanente 3)Cleveland Clinic 4)Intermountain Health Care, 5)Dignity Health,
6) Avera Health—just names of mega hospital major healthcare providers networks with millions of patients getting in on the game...
AND one hell of a big game it’s going to be.
One strategy these players are aiming for is Primary Preventaive Medicine “Primary Care”, ahhh musical notes
to who else, but our cheer leaders the Insurance Companies, a growing garden of health care medical care
payout savings, and wow are they cheering...!
Go iT Bra
So who do you think Cyrcadia Health is targeting ask your self ?—why the extensive clinical trials when they already have FDA Class ll Clearance, and mktg/sales program in Asia just about to begin 2018, because they want to get it right (their AI Artificial intelligence algorithm, also just recently brought to my attention, the medical community is wanting to see the clinical trial data ASAP when it can be released-this will be huge for Cyrcadia Health)
This iT Bra no pun intended fits right into the “Telemedicine Revolution” and the timing could not be better.
(reducing anxiety, commute time/expense/carbon foot print, giving privacy and saving a life for millions of women connected all over the world, ask yourself would you pay less than $100 to possibly save your life & not be exposed to low level radiation, what would an insurance co pay to save millions of dollars ?
Yes the TeleMedicine evolution is here fellow investors (I currently own 2 Mil shares LLBO.
In case anybody was wondering, I have no connection with the company and do my own research).
My hats off to Cyrcadia and Mercy Virtual for preventing/ reducing early unnecessary deaths,
hospital admissions, emergency dept visits, saving untold millions of dollars.
The price of admission is life...
I guess only time and a life saved will answer the question what if
DETECTED ?
(Cisco Corp was instrumental in helping Circadia Health produce a film about their iT Bra called Detected.)
Previous post # 24768, which u can enter the post num at the top GoTo search box above, has information
on some current investors as well as clinical trial data.
Source:
AARP magazine article Feb/March 2018 “Is Telemedicine the Future of Care ”
& “The Digital Doctor Is In”, explores how telemedicine is transforming healthcare.
Excellent article and anyone that invest in any kind of healthcare should definitely read.
(I know one thing the executives at Cyrcadia Health are).
More Info:
Mercy Virtual & the other Mega health institutions, again discussed in this months AARP
journal (April/May) as well as Cisco (per my prior investigative post below), continue to educate the
public on this explosive growth industry-“Virtual Health Care”.
Cyrcadia Health-get the data and the iT Bra out !!!
This technology has never “NEVER” been tested & had advanced algorithmic data collection
based on the very latest technology that it has today...the sensitivity of the senors & AI source
interpretation of data, surpassed Oxford when they were also running test many years ago.
Sensitivity (detection) for women with other conditions-dense breast tissue is approximately 60% & that is many women, but the
iT Bra has a very large
improvement in final outcome sensitivity (Detected).
American Cancer Society facts
“Radiation Exposure”:
Because mammograms are x-ray tests, they expose the breasts to radiation. The amount of radiation from each mammogram is low, but it can still add up over time.
(Time ???)
A false-negative mammogram looks normal even though breast cancer is present. Overall, screening mammograms do not find about 1 in 5 breast cancers.
(=20%, & I have to wait one more year for another mammogram, not if I have the iT Bra!)
Worldwide over 1.7 Million
women will be diagnosed with breast cancer~2018.(25% of all new cancers in women are breast cancer, it is the fifth most common cause of death from cancer in women.)
Netherlands study:
A recent large scale service screening report from the Netherlands involving almost 175,000 cancers with linked data mammography, pathologic conditions, and breast cancer death outcomes. Stated that Breast cancer mortality increased significantly in both studied cohorts (before and after institution of modern chemotherapy) with increasing tumor size for tumors as small as 10 mm. The major conclusion of the report was that “Diagnosis of breast cancer at an early stage remains vital,”
VITAL
hence metrics involving tumor size, lymph node status, and cancer stage continue to be important indicators of quality performance.
****************
With 20% of cases not detected & tumor SIZE so important & I’m going to wait over two years for “2” mammograms???
iT Bra at least gives me a fighting chance.
I truly believe it would be totally insane for the virtual medical market not to be taking a very close look at this technology “iT Bra” and doing what they can to support it.
iFlytek Corp. Invest in Cyrcadia Asia (Cyrcadia Health-Lifeline biotechnologies
LLBO)
China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.
The country’s cancer rates have soared in recent years, caused by people succumbing to the disease due to heavy smoking, pollution and living to an older age, raising concerns about the prevalence of the disease.
Last year, the National Cancer Center reported that there were 4.29 million new cases of the disease every year and 2.81 million deaths.
The five-year cancer survival rate was just 30% in 2015, less than half the US level, prompting the Chinese government to pledge to improve on this by 15 percentage points by 2030.
China’s new medical insurance regulator, The State Medical Insurance Administration, is planning to include more cancer drugs on its list of medicines eligible for reimbursement.
So far, 10 foreign and eight domestic pharmaceutical companies have expressed a willingness to work with the administration to boost availability so more people can benefit from medication, as more drugs are added to the insurance system.
China removed tariffs on all imported cancer drugs from May 1, following a decision by Premier Li Keqiang in April.
Breast cancer is the most common type of cancer in women in China. Data shows that this cancer has increased at a rate of around 3.5% a year from 2000 to 2013, compared with a drop of 0.4% a year over the same period in the US.
Levels are highest in urban areas. In small cities with a population below 500,000, the incidence of breast cancer is 30 per 100,000. For large cities with a population above 1 million, the incidence is 60 per 100,000 women.
iFLYTEK, a global AI giant, has recently invested in breast cancer detection smart bra manufacturer, Cyrcadia Asia (iT Bra -LLBO US stock symbol). In Asia, many women either cannot access healthcare, or are unable to expose their bodies due to social, economic, or religious reasons. For women in many of these countries, discovery of the disease comes too late, and treatment is ineffective.
The iTBra contains two breast patches that detect circadian temperature changes within breast tissue. Anonymised data obtained from the iTBra is communicated directly to the Cyrcadia Health core lab for analysis via PC or smartphone.
Cyrcadia Asia operates under a strategic license and cooperation agreement with US-based Cyrcadia Inc to exclusively manufacture and commercialise the product for markets in Asia.
End
Older post being resurrected :) tic toc
Breast cancer screening: a growing world market12.07.2017
A short view on different markets
~250,000,0000 MILLION Breast Screenings Worldwide ...Say What???
“Breast cancer is the most common cancer in women worldwide, and the number of women affected continues to increase.1 There is thus a large need for early detection options.
China is therefore one of the largest markets for breast cancer screenings, along with the United States, Brazil, Japan, and Germany.” Etc etc.
https://www.healthcare.siemens.nl/mammography/news/breast-cancer-screening-growing-worldwide.html
And to think I only used a fraction of that market for valuation & there’s only one way in to the show...tic tic tic toc...
Welcome PPS ~.22—New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast & looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia AI cloud data center which transmits analysis back to her & Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following POST after drinking a pot of coffee!)))
Previous Informative Post to read: (just enter in search box above GO)...
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
27131 PPS it’s long,but conclusion: pps.22 or more
27094 Co marketing intent: the short “it’s happening”!
27061 Market size & Need: Summary-It’s Huge & Needed
26944 Insurance Co perspective: Ho Ho Ho Merry Christmas, AARP nailed it! $$$
27037 Number of breast cancer cases & importance of earl detection: Your life may depend on it
26370 iFlytech Corp.-Invest in healthcare through acquisition: Say what ?
25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia/World
waiting. Other info.
Hell just buy some shares sit back & think of green grass & high tides!!!
Jim Holmes, Lifeline’sCyrcadia Health CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product. Our tested and proven technology, from our multiple rounds of clinical trials, has shown early identification of breast tissue abnormalities, many of which could lead to cancers, potentially can save lives and costs. We/Cyrcadia prepared an analysis of cost savings for a presentation to a World-Wide Major Insurance Company. The medical cost comparison was identifying breast tissue abnormalities and breast cancers at stage 1-3, vs the abnormality progressing to stage 4 or 5 cancer. The cost savings was estimated at over $300,000 per patient. Applying this projected and estimated cost savings to this large insurance, was in the hundreds of millions of dollars annually. (PPS anybody’s guess ?).
Gold Std...
Post #30415
Well well well, let’s see what Leon Wang: Princeton University Phd researching cancer has to say about the iTBra-
“Skin patches are noninvasive, discrete, and potentially inexpensive enough that I could actually see use by common people on an ordinary basis. Specifically for Cyrcadia and iTBra™, the potential market is huge. There are over 700 million women worldwide between the ages of 20 and 70. In the United States alone, 38 million mammograms are preformed each year. Furthermore, the unacceptably high false positive rate of mammograms leads to an associated cost of over 4 billion dollars in unnecessary treatments annually in the US. If marketed correctly, iTBra™ is not only just a mammogram alternative, it could dominate the entire market
The Bottom Line
Cyrcadia sits on a very mature and proven technology that presents a solution to a “huge” market in which there is no current gold standard. This situation is unique in the startup field and I am very optimistic regarding the future success of iTBra™ and Cyrcadia.”
Tic toc tic...
PPS .22 ??? Or should I recalculate...let’s say on the upside
Full article link:
https://medium.com/startupreview/the-future-of-cancer-diagnostics-vol-3-e3188fefee41
FDA—Should be acting...(sent a letter today asking why my wife has to fly to Hong Kong to try the iT Bra)!!!
In time...
Is Telemedicine the Future of Care
Cyrcadia Health
(Lifeline Biotechnologies
LLBO: 07-.12 target PPS)
Huge mkt for women who want home privacy & life saving ability to do a simple reliable breast examination between annual breast check ups, the iT Bra allows this peace of mind. (And with the new breast screening guidelines out recommending screening every other year after age 54, the IT Bra will be ideal for those long in between screenings, oh and the new guidelines also don’t recommend the old self examination “by hand”, hell let’s just let the tumor grow into an elephant. What’s left the iT Bra or a crystal ball, which would u choose ???)
(Gene identification for breast tumor risk testing is NOT going to change that in any way.)
One such very large medical Co. that is currently being approached by Cyrcadia Health (iT Bra) is-Kaiser Permanente Co. ( mentioned in AARP article below),
Kaiser preaches “Early Diognostic Prevention”...& the iT Bra is something they cannot afford to shrug off.
Virtual Medical Care Huge Future:
Glad to see that Cyrcadia Health will be indirectly involved with Kaiser Permanent
(I brought this up as a target mkt below, prior to their 2017-2018 report release, glad to see they are going right
after the Virtual med mkt.)
Let’s just look at what is literally appearing before our eyes to help answer this question
“This is the future of Medicine...”
Telemedicine Revolution (patients/doctors converse anywhere)—Fact, Hospital Without Patients (virtual care) 2016 mega growth industry had sales of $14 Billion Dollars, growth projection
expected to $36 Billion Dollars by 2020, (2yrs)WOW, project that growth line and
You fall out of your seat (iT Bra I would say is properly named).
Mercy Virtual medical bldg is 6 miles from my home, a mega structure loaded with over
400 doctors, nurse specialist,and med technicians (not one hospital bed). All who supported more than 44 hospitals in the Mercy network,
in over 10 Midwest states (had over 750,000 thousand patients just last year.)
(Why? Patient convenience, privacy, more efficient healthcare, saving money & more important life’s).
1)Mercy Virtual 2)Kaiser Permanente 3)Cleveland Clinic 4)Intermountain Health Care, 5)Dignity Health,
6) Avera Health—just names of mega hospital Major healthcare providers networks with millions of patients getting in on the game...
AND One hell of a big game it’s going to be.
One strategy these players are aiming for is Primary Preventaive Medicine “Primary Care”, ahhh musical notes
to who else, but our cheer leaders the Insurance Companies, a growing garden of health care medical care
payout savings, and wow are they cheering...!
Go iT Bra
So who do you think Cyrcadia Health is targeting ask your self ?—why the extensive clinical trials when they already have FDA Clearance, and mktg/sales program in Asia just about to begin 2018, because they want to get it right (their AI Artificial intelligence algorithm, also just recently brought to my attention the medical community is wanting to see the clinical trial data ASAP when it can be released-this will be huge for Cyrcadia Health)
This iT Bra no pun intended fits right into the “Telemedicine Revolution” and the timing could not be better.
(reducing anxiety, commute time/expense/carbon foot print, giving privacy and saving a life for millions of women connected all over the world, ask yourself would you pay less than $100 to possibly save your life & not be exposed to low level radiation, what would an insurance co pay to save millions of dollars ?
Yes the TeleMedicine evolution is here fellow investors (I am currently holding 2 Mil shares LLBO
in case anybody was wondering, I have no connection with the company and do my own research)
My hats off to Cyrcadia and Mercy Virtual for preventing/ reducing early unnecessary deaths,
hospital admissions, emergency dept visits, saving untold millions of dollars.
The price of admission is life...
I guess only time and a life saved will answer the question what if
DETECTED ?
Previous post # 24768, which u can enter the post num at the top GoTo search box, has information
on some current investors as well as clinical trial data.
Good day to all.
Source:
AARP magazine article Feb/March 2018 “Is telemedicine the future of care” & “The Digital Doctor Is In” , explores how telemedicine is transforming healthcare.
Excellent article and anyone that invest in any kind of healthcare should definitely read.
(I know one thing the executives at Cyrcadia Health are).
More Info:
Mercy Virtual & the other Mega health institutions, again discussed in this months AARP
journal (April/May) as well as Cisco (per my prior investigative post below), continue to educate the
public on this explosive growth industry-“Virtual Health Care”.
Cyrcadia Health-get the data and the iT Bra out !!!
This technology has never “NEVER” been tested & had advanced algorithmic data collection
based on the very latest technology that it has today...the sensitivity of the senors & AI source
interpretation of data, surpassed Oxford when they were also running test many years ago.
Sensitivity (detection) for women with other conditions is approximately 60%(ie: dense breast tissue & that is many women), but the
iT Bra has a very large
improvement in final outcome sensitivity (Detected).
American Cancer Society facts
“Radiation exposure”:
Because mammograms are x-ray tests, they expose the breasts to radiation. The amount of radiation from each mammogram is low, but it can still add up over time.
(Time ???)
A false-negative mammogram looks normal even though breast cancer is present. Overall, screening mammograms do not find about 1 in 5 breast cancers.
(=20%, & I have to wait one more year for another mammogram, not if I have the iT Bra!)
Worldwide over 1.7 Million
women will be diagnosed with breast cancer.(25% of all new cancers in women are breast cancer, it is the fifth most common cause of death from cancer in women.)
Netherlands study:
a recent large-scale service screening report from the Netherlands involving almost 175,000 cancers with linked data mammography, pathologic conditions, and breast cancer death outcomes. Breast cancer mortality increased significantly in both studied cohorts (before and after institution of modern chemotherapy) with increasing tumor size for tumors as small as 10 mm. The major conclusion of the report was that “Diagnosis of breast cancer at an early stage remains vital,”
VITAL—hence, metrics involving tumor size, lymph node status, and cancer stage continue to be important indicators of quality performance.
****************
(so we have 20% of cases not detected & tumor SIZE so important & I’m going to wait over two years for “2” mammograms???
iT Bra at least gives me a fighting chance.
I truly believe it would be totally insane for the virtual medical market not to be taking a very close look at this technology “iT Bra” and doing what they can to support it.
Happy B Day ...come on FDA
Let’s hope FDA pulls the stick out of its pie hole & gets this life saving device on the market...!
Let’s hope Cyrcadia is pressing the FDA, maybe good time for a press release...!
Arnie, right on...at least their still alive & the telemedicine mkt evolves daily tic toc when the clock strikes 12 anybody’s guess, but I know one given is LLBO will become a hot commodity...!
FDA class II Substantially changed devices will need to be reviewed before marketing clearance will be issued by the fda...
(simply put can’t market the device due to device applied application time/ AI software changes are re approved )
Your Probably aware the iT Bra went through technology upgrades, these changes substantially changed the
efficacy for the better, but still need FDA review.
This is why their website states-“The product is not currently available for sale in the United States.“
& Cyrcadia Asia states ”FDA Class II clearance issued with further clearances in process.”
Will Covid-19 hasten or impede the FDA & US continued trial...will see !
Like I said two wks ago (4/12/20 below), same as Cyrcadia Asia “FDA Class 11 Clearance issued with further Clearances in process“. Tic toc
04/12/20 10:48:20 AM
Re: None 0
Post # of 30325
iT Bra Was submitted to FDA sometime back initially had approval until algorithms were changed & device set up
was changed... The only thing they need now is some efficacy Of the changes...Free market notification substantially “equivalent” (or improved) to prior device meeting class two ...tic toc
And yes given the change in world views / regulatory bodies (FDA etc.) are looking at telemedicine home diagnostics, as I previously reported Several years ago The approval of the iT bra would in all likelihood send the stock north extremely fast...13
Happy Easter ...Mead ll
Also, PPS previously calculated & Other juicy articles, statistics,etc(Leon Wang’s very optimistic future for Cyrcadia. From previous post...Below
02/04/19 07:10:08 AM
Re: leprisonnier post# 28700 0
Post # of 30331
Valuation LLBO ...”Quote:
“On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer every 13 minutes”. (very sad, my mom was one of them)
New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia Data Services Inc. (AI Cloud Data Base) which transmits analysis back to the Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following post after drinking a pot of coffee!
Just Enter any of the below listed post # in the search box above and click “GO”
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
#27131 PPS it’s long, but conclusion pps.22 or more (valuation only used sales factor of <1% of 700Million + women, also keep in mind “annual” breast screening >250Million clinical checks)
#27094 Co marketing intent, the short “it’s happening”!
#27061 Market size & Need, Summary-It’s Huge & Needed
#26944 Insurance Ins perspective-Ho Ho Ho Merry Christmas, AARP nailed it!
#27037 Number of breast cancer cases & importance of earl detection- Your life may depend on it
#26370 iFlytech Corp.-Invest in healthcare through acquisition- Say what ?
#25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia waiting!
Quote:
“On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer every 13 minutes.”
Source Article:
https://www.nationalbreastcancer.org/breast-cancer-facts
https://www.reuters.com/brandfeatures/venture-capital/article?id=14381&pid=3036&pp=undefined
Hell just buy some shares sit back & think of Green Grass & High Tides...tic toc
(But seriously how do I really feel about a speculative penny stock I’ve owned for 10 yrs., & many release target
dates missed...? Well face to face while enjoying our favorite beverage, I’d say son of a bitch this thing is really
finally going to happen...and if it saves just one life of the women who would of died every “13” minutes I’ll crack a big smile & say job well done Cyrcadia team !)
Hell even if you lower my PPS above by the current percentage ownership of Cyrcadia Asia 30% (and not factoring on unaccounted world markets )...PPS is .15.
And this does not nearly factor in the current situation in the world, which could change things substantially on the upside PPS...Anybody ever heard of Tulip Mania in the Netherlands -contract prices for tulips went through extraordinary high levels of frenzy trading...tic toc tic. 13
iT Bra Was submitted to FDA sometime back initially had approval until algorithms were changed & device set up
was changed... The only thing they need now is some efficacy Of the changes...Free market notification substantially “equivalent” (or improved) to prior device meeting class two ...tic toc
And yes given the change in world views / regulatory bodies (FDA etc.) are looking at telemedicine home diagnostics, as I previously reported Several years ago The approval of the iT bra would in all likelihood send the stock north extremely fast...13
Happy Easter ...Mead ll
”Finally, for the subset of higher-risk digital health devices that are outside of the FDA's COVID-19 policy, the FDA is interested in engaging with manufacturers through the Emergency Use Authorization process to help expand access to critical medical products for use during the COVID-19 pandemic. More information about the FDA's EUA process can be found in the...”
“The broad scope of digital health includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine.
These technologies can empower consumers to make better-informed decisions about their own health and provide new options for facilitating prevention, early diagnosis of life-threatening diseases, and management of chronic conditions outside of traditional care From mobile medical apps and software that support the clinical decisions doctors make every day to artificial intelligence and machine learning, digital technology has been driving a revolution in health care. Digital health tools have the vast potential to improve our ability to accurately diagnose and treat disease and to enhance the delivery of health care for the individual.”
“Why Is the FDA Focusing on Digital Health?—
Many medical devices now have the ability to connect to and communicate with other devices or systems. Devices that are already FDA approved, authorized, or cleared are being updated to add digital features. New types of devices that already have these capabilities are being explored.”
Etc etc etc
((All above information is from FDA.Gov)) https://www.fda.gov/medical-devices/digital-health
Well maybe just maybe we will be one of the lucky winners in this new FDA approach to the modern world...
(I’m sure Cyrcadia is pushing hard)!!!
13...
What a bed wetter
Hospital CEO talks medical technology with retired teachers:
https://www.heraldbulletin.com/news/hospital-ceo-talks-medical-technology-with-retired-teachers/article_fa28d15c-d0e8-11e9-a9d9-6f2c8df54cb9.html
Good for Beth, keeping up with technology. Looks like Cyrcadia mktg may be doing their thing...tic toc come on FDA 13
“But it was Cyrcadia Health’s iTbra that got the biggest reaction from the more than 70 retired educators”
“It is becoming more accurate at detecting breast cancer than mammograms,” Tharp said.
iTBra being mailed to women around the world so they can remote home breast medical checkups...
...telemedicine is the future, where’s the FDA when u need them the most!!! Tic toc tic 13
Spam hurts when it’s the truth, now doesn’t it...
I think I’ll go drink a Home Brew now...!
It Lives...
https://www.google.com/amp/s/markets.businessinsider.com/amp/news/the-wearable-ai-market-in-china-2020-2025-ai-based-smartwatches-fitness-bands-expected-to-witness-lucrative-growth-1028913213
Excerpt:
“China's Wearable AI Market is estimated to grow significantly at a CAGR of 29.6% during the forecast period.”
“In July 2018, iFlytek, China-based AI technology company has further enhanced its healthcare offerings by leading the Pre-A round investment into Cyrcadia Asia, a company indulged in manufacturing smart wearable vest that provides accurate early breast cancer detection.”
(They go into more detail about iFlytech than the other companies, in the intro. Haven’t heard much about iFlytech Co. since they invested in Cyrcadia Asia 11/2 yrs agoHopefully they’ll see some of that annual 30% growth.) tic toc...
Good news to come...?...Maybe we fly to $.135/PPS
Mead we need divine intel!!!
Ask Pharma or Homebrew, I’m sure they’d be glad to tell u all about it...
Traxcn has had Cyrcadia on their radar for a while...
The most recent is Jan 2020 article & the Dec 2019–article
naming the top 10 co picks out of 44 cos involved with
“ women’s wearables”, Cyrcadia Health & Cyrcadia Asia
we’re both picked as top 10 in that article or 20% ...
I guess a bird in hand is worth 2 in the Bush!!!
Ho Ho Ho, in honer of Meade OL Boy
https://https://tracxn.com/d/trending-themes/Startups-in-Wellness-Wearables-for
Cyrcadia Health/Cyrcadia Asia
Last Updated: January 17, 2020
Last Updated: December 4, 2019
Great to see you Cyrcadia Health/ Cyrcadia Asia two out of TOP 10, out of 44 worldwide women smart device companies...tic toc 13...
XU is a heavy hitter ...Look for more news to come in the coming months -good news
Nice find SVEN...13...
Sure, the race is on...puts more pressure on, plus it will take years for them to get to where the iTBra is
IN MEMORY Of MEAD:
MEAD II
Sunday, March 10, 2019 2:54:37 PM
The best news is that CA is moving forward into Asia. When CI launches into Europe and the US they will have the benefit of the CA launch template and we will exercise a refined version to scale into new markets with greater efficiencies. Tic Toc Tic
Sunday, March 10, 2019 7:58:24 AM
Re: None
Post # of 29651
“Huge Business Potential”...Just love those words...tic toc
“Having the possibility to perform medical checks at one’s fingertips, while going about your daily business in fast-paced Hong Kong is truly game-changing and, at the same time, brings peace of mind to patients,” commented Grace Lau, Head, Management, Hong Kong, DKSH Hong Kong. “We see huge business potential for Cyrcadia Asia and we are dedicated to supporting Hong Kong companies to expand their innovative healthcare solutions in and beyond Hong Kong.”
http://dksh.com/global-en/home/media/news?id=tag:xml.newsbox.ch,2019-01-21:1101.1455.digest
“DKSH is driving education in medical channels through its strong sales workforce and will soon roll-out this medical device to the over-the counter markets in a one-stop-shop model for both Hong Kong and Macau.”
“Over The Counter”...Really Love Those Words...tic toc $$$
A French-Swiss research team is developing a “smart bra” for detecting breast cancer more accessible than through mammography.
Leprisonaires earlier post Sep 19...
( I don’t see any connection to the IT bra, but to say they have not seen the IT bra technology would be rather naïve, So I concluded they are impressed with the technology and are running their own version of it)???
So the Frenchies r getting into the game, Looks like somebody liked our technology...
Who knows maybe this could accelerate a buy out. Probably still too early for much news from Hong Kong ?